Background: The combination of the fast-metabolizing alcohol dehydrogenase-1B (ADH1B*2 allele) and inactive heterozygous aldehyde dehydrogenase-2 (ALDH2*1/*2) increases susceptibility to macrocytic anemia and leukocytopenia in alcoholics due to severe acetaldehydemia. More than half of Japanese drinkers with esophageal cancer have this genotype combination. Methods: To assess the recovery of hematologic abnormalities after drinking cessation, changes in blood erythrocyte indices and leukocyte count during 8-week hospital stay were evaluated in 925 Japanese alcoholic men. We used four categories in ascending order for high blood acetaldehyde exposure from drinking: A, ADH1B*1/*1 plus ALDH2*1/*1; B, ADH1B*2 plus ALDH2*1/*1; C, ADH1B*1/*1 plus ALDH2*1/*2; and D, ADH1B*2 plus ALDH2*1/*2. Results: Mean values of hemoglobin and hematocrit were the lowest, and those of mean corpuscular volume (MCV) were markedly the highest in the D group on admission, and returning toward normal after abstinence, but the inter-group differences remained significant throughout the 8 weeks. The mean leukocyte count was the lowest in the D group on admission, but increased during 4-week abstinence when the inter-group differences were no longer significant. Frequencies of MCV ≥110 fl (50.5%), hemoglobin levels <11.5 g/dL (32.7%), hemoglobin levels <10.0 g/dL (9.9%) and leukocytopenia <4000/μL (22.8%) were the highest in the D group on the admission day and decreased at the 4-week abstinence (28.7%, 18.8%, 4.0% and 7.9%, respectively). The inter-group differences in frequencies of the severe anemia and leukocytopenia disappeared after 4-week abstinence. Conclusions: Drinking cessation before surgery and/or chemoradiation treatment for esophageal cancer may be effective for recovery from anemia and leukocytopenia in drinkers belonging to the D group.
Introduction
In East Asians, the fast-metabolizing form of alcohol dehydrogenase-1B (ADH1B, rs1229984) is encoded by ADH1B*2 allele and the inactive form of aldehyde dehydrogenase-2 (ALDH2, rs671) is encoded by ALDH2*2 allele (1-3). Both alleles have been found to have an inhibitory effect on alcohol drinking due to the severe acetaldehydemia and intense flushing responses in comparison with the slow-metabolizing ADH1B encoded by ADH1B*1/*1 and the active ALDH2 encoded by ALDH2*1/*1, respectively (1-3).
Macrocytosis, macrocytic anemia and leukocytopenia are common in alcoholics, and diminution in marrow granulocyte reserves has been demonstrated (4, 5) . Examination of the bone marrow of alcoholics has revealed the presence of vacuolated granulopoietic progenitors exhibiting asynchronous maturation of their nucleus and cytoplasm (6) . The combination of ADH1B*2 allele and ALDH2*1/*2 genotype greatly increase susceptibility to macrocytosis, macrocytic anemia and leukocytopenia, suggesting a critical role of acetaldehyde in the erythrocyte and leukocyte alterations (7, 8) .
High levels of acetaldehyde exposure by drinkers play a critical role in the carcinogenesis of esophageal squamous cell carcinoma (ESCC) (9-13) related to alcohol drinking. Indeed, the classification of acetaldehyde related to alcohol drinking as 'carcinogenic to humans' (Group 1) by the International Agency for Research on Cancer (10) is based in large part on epidemiologic studies showing a dramatically elevated risk of ESCC in alcohol drinkers with the ALDH2*1/*2 genotype. A large Japanese study has been reported that the frequency of the ADH1B*2 allele and ALDH2*1/*2 genotype combination was 64% and 24%, respectively, in habitual drinkers with and without ESCC (11) .
The Japanese Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus (14) recommends 1-month smoking cessation before surgery of esophageal carcinoma to achieve the better outcome, but makes no reference to alcohol drinking. However, acetaldehyde-induced anemia and leukocyte suppression may have a negative effect on the outcome of surgery and/or chemoradiation therapy for esophageal carcinoma in heavy drinkers especially with the ADH1B*2 plus ALDH2*1/*2 combination.
The aims of present study were to investigate the recovery process of the abnormalities in blood erythrocyte indices and leukocyte count after abstinence according to the genotype combinations of ADH1B and ALDH2 in Japanese alcoholic men.
Materials and methods
The study patients consisted of 925 Japanese alcoholic men aged 40 years or over who met the following criteria: (a) admitted to the Kurihama Medical and Addiction Center for treatment of alcohol dependence for the first time within 1 week of their last drink with a high serum level of gamma-glutamyl transpeptidase ≥48 IU/L on the day of admission between May 2004 and December 2011, (b) underwent routine blood examinations on all the 3 days of admission and of~1 and 4 weeks after admission, (c) did not receive blood transfusions but received standard treatment that includes a balanced diet and 2-day administration of vitamins including folate and vitamin B12 in intravenous fluid, and (d) underwent ADH1B and ALDH2 genotyping. A majority of the subjects underwent additional blood examinations on the days of~2, 6 and 8 weeks after admission according to their length of stay during the inpatient rehabilitation program. The subject number who underwent blood examinations was 925, 925, 917, 925, 873 and 796 on the day of admission and of~1, 2, 4, 6 and 8 weeks after admission, respectively. We evaluated the subjects for associations between their changes in blood erythrocytes indices and leukocyte count after abstinence and their ADH1B and ALDH2 genotypes. The ethics committee of the Center reviewed and approved the proposed study, and each of the participants gave his informed consent.
All of the alcoholics who participated in this study met the DSM-IV criteria for alcohol dependence (15) . A complete blood cell count was performed with an autoanalyzer (CELL-DYN 3500, Abbott, North Chicago, IL). ADH1B and ALDH2 genotyping by using lymphocyte DNA samples was performed according to the method described elsewhere (7) . We classified the ADH1B and ALDH2 genotype combinations into four categories: A group, ADH1B*1/*1 plus ALDH2*1/*1; B group, ADH1B*2 allele plus ALDH2*1/*1; C group, ADH1B*1/*1 plus ALDH2*1/*2; and D group, ADH1B*2 allele plus ALDH2*1/*2 ( Table 1) .
Statistical analysis
Values were expressed as means and standard deviation (SD) or standard error (SE), medians plus 25th and 75th percentiles (Q1, Q3), or percentage values. An analysis of variance (ANOVA) was used to compare normally distributed data. The Kruskal-Wallis test was used to compare non-normally distributed data. Fisher's exact test was used to compare frequency data.
The interaction between weeks and the genotype groups was tested using a mixed-effect model for repeated measurement data, where a significant interaction indicated a difference in the timedependent patterns among the genotype groups. An analysis of covariance (ANCOVA) and a logistic regression analysis were used to compare the mean values and the percentage values, respectively, at each time adjusted for age and the presence of liver cirrhosis.
All the statistical analyses were performed by using the SAS software program (version 9.4; SAS Institute, Cary, NC). Results Table 2 shows the backgrounds of the subjects according to the ADH1B and ALDH2 genotype combination. Younger age was observed in the A group and the prevalence of liver cirrhosis was highest in the B group and the lowest in the C group. There were no differences in alcohol consumption and smoking according to the genotype combination.
The mean values of hemoglobin and hematocrit were the lowest in the D group, intermediate in the B and C groups, and the highest in the A group on the day of admission (Fig. 1) . These values transiently decreased during the first week. These values of the C and D groups then continued to increase until 4-week abstinence. The mean value of mean corpuscular volume (MCV) was the highest in the D group, intermediate in the C group, and the lowest in the A and B groups on the day of admission. The value slightly increased at the first week, and then consistently decreased regardless of the group category throughout the 8-week abstinence. Inter-group differences in hemoglobin, hematocrit, and MCV were significant throughout the 8-week abstinence. The lower mean value of leukocyte count was observed only in the D group at the admission. After a transient decrease at the first week, the leukocyte count in the D group increased, and the inter-group differences were no longer significant after 4-week abstinence. Frequencies of hemoglobin levels <11.5 g/dL, hemoglobin levels <10.0 g/dL, MCV ≥110 fl, and leukocytopenia <4000/μL were the highest in the D group on the admission day (Fig. 2) . After slight increase at the first week, all the frequencies in the D group decreased, and the inter-group differences in hemoglobin levels <10.0 g/dL and leukocytopenia <4000/μL disappeared after 4-week abstinence. Figure 3 shows the changes in counts of granulocytes, monocytes, and lymphocytes during 8-week period after admission according to ADH1B and ALDH2 genotype combinations. Notably, a different recovery pattern was observed in granulocyte, monocyte and lymphocyte counts, regardless of their ADH1B and ALDH2 genotype combinations. The granulocyte counts transiently decreased during the first week, and then increased by 4 weeks and gradually decreased after that. The monocyte counts transiently increased during the first week, and gradually decreased after that. The lymphocyte count increased markedly during the first week, and then stabilized level after that.
Discussion
This study demonstrated that the recovery process of macrocytosis, anemia, and leukocytopenia after abstinence in alcoholics differed by the genotype combinations of ADH1B and ALDH2. Macrocytosis in alcoholics has been demonstrated to slowly resolve during long-term abstinence periods (16) . In the present study, the recovery from the erythrocyte alterations after abstinence was slower in comparison with the suppressed leukocyte count in the alcoholics, especially in those with ADH1B*2 allele and ALDH2*1/*2 genotype combination, i.e. the D group. The persistence in red cell abnormalities reflected the initial values on admission, which were strongly determined by the magnitude of blood acetaldehyde exposure according to the genotype categories. These findings can also be partly explained by the long life span of red blood cells (120 days), since the suppressive effects of the genotypes on the leukocyte counts had disappeared by 4 weeks after admission.
The ALDH2*1/*2 genotype is a major determinant of high blood acetaldehyde exposure after alcohol drinking. Although an ADH1B*2 allele did not have any effect on blood acetaldehyde levels after alcohol challenge tests using moderate doses of ethanol in non-alcoholics (17, 18) , previous studies have suggested that blood acetaldehyde exposure is highest in drinkers belonging to the D group: (a) the D group is most likely to exhibit alcohol flushing responses, which are associated with intense acetaldehydemia (19) (20) (21) (22) (23) (24) ; (b) the slope of the increase in blood acetaldehyde levels according to increase in blood ethanol levels was the steepest for the intoxicated alcoholics belonging to the D group (25); (c) the highest levels of N2-ethylidene-dG, an acetaldehyde-DNA adduct, were detected in the leukocytes of alcoholics belonging to the D group (26) and (d) basal DNA damage in leukocytes as assessed using an alkaline comet assay was highest in habitual drinkers belonging to the D group (27) . Thus, the highest frequency and the slowest recoveries from macrocytosis, anemia, and leukocytopenia observed after the cessation of drinking among alcoholics belonging to the D group suggest the strongest bone marrow suppression as a result of the highest blood acetaldehyde exposure. The ALDH2-associated macrocytosis and anemia have been shown to depend on alcohol consumption in non-alcoholic populations (28, 29) , and were observed both in the C and D groups in this study. The threshold levels of granulocyte/macrophage progenitor cells to inhibition of acetaldehyde in vitro have been reported to be much higher as compared with erythroid progenitor cells (30) , which may partly explain why leukocyte suppression was prominent only in the D group.
We observed a transient exaggeration of erythrocyte indices and a transient decrease of total leukocyte counts at the first week after admission regardless of ADH1B and ALDH2 genotype combinations. Since the hematocrit transiently decreased during the first week, these changes may reflect the recovery process from alcoholismassociated dehydration in the blood.
A low BMI has been found to be a significant determinant of macrocytosis, macrocytic anemia, and leukocytopenia in Japanese alcoholic men (7, 8) . Low BMIs in Japanese alcoholic men were associated with poor dietary habits, such as meal-skipping and a low frequency of milk intake (31) . Folate deficiency is a pathogenetic factor in the onset of anemia and leukocytopenia (32) . Heavy drinking is associated with impaired folate absorption and metabolism (33) . Although the dietary habits before admission and the nutritional status including the folate levels at the time of admission were not investigated in this study, the nutritional improvement after admission might have influenced the recoveries of the erythrocyte and leukocyte statuses. Further study is needed to evaluate the interactions between the nutritional status and the erythrocyte and leukocyte statuses.
We found a different recovery pattern of granulocyte, monocyte and lymphocyte counts during recovery form alcohol drinking. Each pattern was independent of their ADH1B and ALDH2 genotype combinations, and therefore acetaldehyde levels. These observations suggest the existence of blood cell-type specific factors that influence Change in blood granulocyte, monocyte, and lymphocyte count after abstinence in hospital in Japanese alcoholic men. P < 0.001 for interaction between weeks and the genotype groups for any of the leukocyte indices according to a mixed-effect model for repeated measurement data; a significant interaction means the recovery patterns are different between the genotype groups. **P < 0.001 and *P < 0.05 using an ANCOVA for homogeneity among the four groups adjusted for age and presence of the liver cirrhosis at each week. recovery process after abstinence in alcoholics. It is commonly observed that monocytes appear rapidly in the blood compared with neutrophils during hematopoietic recovery in myelosuppressive patients, which is consistent with our result. A difference in the cell division history from the progenitor cells might account for the phenomenon (34) . The total lymphocyte count has been used as an indicator of malnutrition (35) . The rapid increase in the lymphocyte count after admission might have reflected a concurrent improvement in the nutritional status. The present study had several limitations. The subjects reported drinking within 1 week before admission. Recall bias and the reliability of the responses of alcoholics asked about their last drink are always problematic. Other factors may modify the recovery process of erythrocyte and leukocyte alterations, such as physical activity, severity of alcohol use disorders, and physical complications. Generalization of the results obtained in our study based on an investigation of treatment-seeking alcoholic men will require confirmation among various drinking populations, including cases with mild alcoholism and non-alcoholics.
Drinking in ALDH2*1/*2 carriers is a strong risk factor for squamous cell carcinoma in the esophagus and the head and neck (9) (10) (11) (12) (13) . The majority of these cancers are detected at advanced stages, and treated by surgery and/or chemoradiation (36) . The genotype combination characterizing the D group is very common (e.g. 64%) (11) among Japanese drinkers with ESCC. According to Japanese Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus (14), a safety standard to receive chemoradiation treatment includes hemoglobin ≥10.0 g/dL and leukocyte count ≥4000/μL as well as good results of liver function tests. The present study showed that anemia and leukocytopenia disappeared in many of the alcoholic patients by 4-week abstinence. The discovery of acetaldehyde-associated anemia and leukocytopenia warrants investigation of the effectiveness of drinking cessation as means of preventing complications of cancer treatment, such as anemia, leukocytopenia and infection, according to ADH1B and ALDH2 genotype combinations.
